Biomarker-guided antifungal stewardship policies for patients with invasive candidiasis

Area of Science:

• Medical Mycology
• Infectious Diseases
• Healthcare Policy

Background:

• Invasive fungal infections (IFIs) pose a significant threat to immunocompromised patients, leading to high mortality rates and substantial healthcare costs.
• Current culture-based diagnostic methods for IFIs are time-consuming, delaying critical treatment.
• The rise of antibiotic resistance necessitates improved strategies for antifungal use, aligning with antibiotic stewardship principles.

Purpose of the Study:

• To review novel diagnostic biomarkers for early detection of invasive candidiasis.
• To explore the integration of antifungal stewardship programs into healthcare policies.
• To propose a unified health policy for managing systemic candidiasis in immunocompromised individuals.

Main Methods:

• Literature review of diagnostic approaches for invasive fungal infections.
• Analysis of serologic and molecular detection methods.
• Examination of antifungal stewardship guidelines and their impact.

Main Results:

• Novel diagnostic biomarkers offer potential for earlier and more accurate detection of IFIs compared to traditional methods.
• Antifungal stewardship programs can optimize antifungal use, reduce resistance, and lower healthcare costs.
• Integrating diagnostic advancements with stewardship strategies can lead to improved patient outcomes.

Conclusions:

• Early diagnosis and effective antifungal stewardship are crucial for improving survival rates in patients with IFIs.
• A comprehensive health policy addressing both diagnostics and stewardship is needed for optimal management of systemic candidiasis.
• Further research into novel biomarkers and stewardship interventions will enhance the fight against life-threatening fungal infections.